Methyldopa (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Methyldopa drug offered from Mylan Institutional Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
NON-PROPRIETARY NAME: | methyldopa |
SUBSTANCE NAME: | METHYLDOPA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1998-09-01 |
END MARKETING DATE: | 0000-00-00 |
Methyldopa HUMAN PRESCRIPTION DRUG Details:
Item Description | Methyldopa from Mylan Institutional Inc. |
LABELER NAME: | Mylan Institutional Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 1998-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51079-200_3b73fe46-ac87-657c-e054-00144ff88e88 |
PRODUCT NDC: | 51079-200 |
APPLICATION NUMBER: | ANDA070076 |
Other METHYLDOPA Pharmaceutical Manufacturers / Labelers: